About Carboxypeptidase N catalytic chain
Carboxypeptidase N catalytic chain (CPN1) is a protein
from Homo sapiens identified by UniProt accession
P15169, 458 residues long.
MolForge cross-references it against 0 known binders and
163 disease associations.
Target properties
| Protein name | Carboxypeptidase N catalytic chain |
| UniProt accession | P15169 |
| Gene | CPN1 |
| Organism | Homo sapiens |
| Length | 458 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (163)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.51
- body height · score 0.44
- heel bone mineral density · score 0.42
- serum alanine aminotransferase measurement · score 0.42
- protein measurement · score 0.41
- interleukin-27 measurement · score 0.40
- creatine kinase measurement · score 0.36
- bone quantitative ultrasound measurement · score 0.34
- neurodegenerative disease · score 0.33
- blood phosphate measurement · score 0.33
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P15169-F1 | alphafold | PREDICTED | 90.75 | — |
Amino-acid sequence (458 residues)
MSDLLSVFLH LLLLFKLVAP VTFRHHRYDD LVRTLYKVQN ECPGITRVYS IGRSVEGRHL YVLEFSDHPG IHEPLEPEVK YVGNMHGNEA LGRELMLQLS EFLCEEFRNR NQRIVQLIQD TRIHILPSMN PDGYEVAAAQ GPNKPGYLVG RNNANGVDLN RNFPDLNTYI YYNEKYGGPN HHLPLPDNWK SQVEPETRAV IRWMHSFNFV LSANLHGGAV VANYPYDKSF EHRVRGVRRT ASTPTPDDKL FQKLAKVYSY AHGWMFQGWN CGDYFPDGIT NGASWYSLSK GMQDFNYLHT NCFEITLELS CDKFPPEEEL QREWLGNREA LIQFLEQVHQ GIKGMVLDEN YNNLANAVIS VSGINHDVTS GDHGDYFRLL LPGIYTVSAT APGYDPETVT VTVGPAEPTL VNFHLKRSIP QVSPVRRAPS RRHGVRAKVQ PQARKKEMEM RQLQRGPA
Explore Carboxypeptidase N catalytic chain with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets